Home - Products - Others - Other Targets - [D-Phe6,Leu-NHEt13,des-Met14]-Bombesin (6-14)

[D-Phe6,Leu-NHEt13,des-Met14]-Bombesin (6-14)

CAS No. 124199-90-2

[D-Phe6,Leu-NHEt13,des-Met14]-Bombesin (6-14)( ——— )

Catalog No. M42101 CAS No. 124199-90-2

(D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) is a bombesin (BBN) antagonist and can be used for the research of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [D-Phe6,Leu-NHEt13,des-Met14]-Bombesin (6-14)
  • Note
    Research use only, not for human use.
  • Brief Description
    (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) is a bombesin (BBN) antagonist and can be used for the research of cancer.
  • Description
    (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) is a bombesin (BBN) antagonist and can be used for the research of cancer.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    124199-90-2
  • Formula Weight
    984.12
  • Molecular Formula
    C49H69N13O9
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Podstawka E, et al. Potential-dependent studies on the interaction between phenylalanine-substituted bombesin fragments and roughened Ag, Au, and Cu electrode surfaces. J Phys Chem B. 2010 Jan 21;114(2):1010-29.?
molnova catalog
related products
  • Phthalylsulfacetamid...

    Parenteral sulfonamides for dysentery, enteritis, and prevention of intestinal infection after surgery.

  • Terlipressin

    Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

  • Polygalic acid

    Triterpenoid saponin. Shows expectorant, emetic and stimulant effects. Orally active.